Heterogeneity in Dopamine Neuron Synaptic Actions Across the Striatum and Its Relevance for Schizophrenia

Biological Psychiatry

Volumn 81, Issue 1, 2017, Pages 43-51

  Chuhma, Nao ^a,b   Mingote, Susana ^a,b   Kalmbach, Abigail ^a,b   Yetnikoff, Leora ^a,b   Rayport, Stephen ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

Author keywords

Corelease; Cotransmission; GABA; Glutamate; Nucleus accumbens; Optogenetics; Vesicular synergy

Indexed keywords

4 AMINOBUTYRIC ACID; DOPAMINE; DOPAMINE RECEPTOR; GLUTAMIC ACID; NEUROLEPTIC AGENT; NEUROTRANSMITTER; PSYCHOSTIMULANT AGENT; PSYCHOTROPIC AGENT; 4 AMINOBUTYRIC ACID RECEPTOR;

CORPUS STRIATUM; CYTOARCHITECTURE; DOPAMINE RELEASE; DOPAMINE UPTAKE; DOPAMINERGIC NERVE CELL; DRUG MECHANISM; HUMAN; NERVE CELL; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SYNAPSE VESICLE; ANIMAL; DRUG EFFECTS; MOUSE; PATHOPHYSIOLOGY; PHYSIOLOGY; SYNAPSE; SYNAPTIC TRANSMISSION;

ANIMALS; CORPUS STRIATUM; DOPAMINE; DOPAMINERGIC NEURONS; GABAERGIC NEURONS; GLUTAMIC ACID; HUMANS; MICE; PSYCHOTROPIC DRUGS; RECEPTORS, DOPAMINE; SCHIZOPHRENIA; SYNAPSES; SYNAPTIC TRANSMISSION;

EID: 84997208303     PISSN: 00063223     EISSN: 18732402     Source Type: Journal    
DOI: 10.1016/j.biopsych.2016.07.002     Document Type: Review

References (138)

1. 1 Howes, O.D., Kambeitz, J., Kim, E., Stahl, D., Slifstein, M., Abi-Dargham, A., et al. The nature of dopamine dysfunction in schizophrenia and what this means for treatment. Arch Gen Psychiatry 69 (2012), 776–786.
2. 2 Di Chiara, G., Imperato, A., Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci U S A 85 (1988), 5274–5278.
3. 3 Drevets, W.C., Price, J.C., Kupfer, D.J., Kinahan, P.E., Lopresti, B., Holt, D., et al. PET measures of amphetamine-induced dopamine release in ventral versus dorsal striatum. Neuropsychopharmacology 21 (1999), 694–709.
4. 4 Colpaert, F.C., Discovering risperidone: The LSD model of psychopathology. Nat Rev Drug Discov 2 (2003), 315–320.
5. 5 Lieberman, J.A., Bymaster, F.P., Meltzer, H.Y., Deutch, A.Y., Duncan, G.E., Marx, C.E., et al. Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacol Rev 60 (2008), 358–403.
6. 6 Kegeles, L.S., Abi-Dargham, A., Frankle, W.G., Gil, R., Cooper, T.B., Slifstein, M., et al. Increased synaptic dopamine function in associative regions of the striatum in schizophrenia. Arch Gen Psychiatry 67 (2010), 231–239.
7. 7 Egerton, A., Chaddock, C.A., Winton-Brown, T.T., Bloomfield, M.A., Bhattacharyya, S., Allen, P., et al. Presynaptic striatal dopamine dysfunction in people at ultra-high risk for psychosis: Findings in a second cohort. Biol Psychiatry 74 (2013), 106–112.
8. 8 Margolis, E.B., Coker, A.R., Driscoll, J.R., Lemaître, A.-I., Fields, H.L., Reliability in the identification of midbrain dopamine neurons. PLoS One, 5, 2010, e15222.
9. 9 Pupe, S., Wallén-Mackenzie, A., Cre-driven optogenetics in the heterogeneous genetic panorama of the VTA. Trends Neurosci 38 (2015), 375–386.
10. 10 Anderegg, A., Poulin, J.-F., Awatramani, R., Molecular heterogeneity of midbrain dopaminergic neurons - Moving toward single cell resolution. FEBS Lett 589 (2015), 3714–3726.
11. 11 Roeper, J., Dissecting the diversity of midbrain dopamine neurons. Trends Neurosci 36 (2013), 336–342.
12. 12 Liss, B., Roeper, J., Individual dopamine midbrain neurons: Functional diversity and flexibility in health and disease. Brain Res Rev 58 (2008), 314–321.
13. 13 Lammel, S., Lim, B.K., Malenka, R.C., Reward and aversion in a heterogeneous midbrain dopamine system. Neuropharmacology 76 (2014), 351–359.
14. 14 Margolis, E.B., Mitchell, J.M., Ishikawa, J., Hjelmstad, G.O., Fields, H., Midbrain dopamine neurons: Projection target determines action potential duration and dopamine D2 receptor inhibition. J Neurosci 28 (2008), 8908–8913.
15. 15 Mrejeru, A., Marti-Prats, L., Avegno, E.M., Harrison, N.L., Sulzer, D., A subset of ventral tegmental area dopamine neurons responds to acute ethanol. Neuroscience 290 (2015), 649–658.
16. 16 Sulzer, D., Surmeier, D.J., Neuronal vulnerability, pathogenesis, and Parkinsonʼs disease. Mov Disord 28 (2013), 715–724.
17. 17 Brichta, L., Greengard, P., Molecular determinants of selective dopaminergic vulnerability in Parkinson׳s disease: an update. Front Neuroanat, 8, 2014, 152.
18. 18 Wickham, R.J., Addy, N.A., Wightman, M., Advances in studying phasic dopamine signaling in brain reward mechanisms. Front Biosci (Elite Ed) 5 (2013), 982–999.
19. 19 Tsai, H.C., Zhang, F., Adamantidis, A., Stuber, G.D., Bonci, A., de Lecea, L., et al. Phasic firing in dopaminergic neurons is sufficient for behavioral conditioning. Science 324 (2009), 1080–1084.
20. 20 Petreanu, L., Huber, D., Sobczyk, A., Svoboda, K., Channelrhodopsin-2-assisted circuit mapping of long-range callosal projections. Nat Neurosci 10 (2007), 663–668.
21. 21 Chuhma, N., Tanaka, K.F., Hen, R., Rayport, S., Functional connectome of the striatal medium spiny neuron. J Neurosci 31 (2011), 1183–1192.
22. 22 Smith, A.D., Bolam, J.P., The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 13 (1990), 259–265.
23. 23 Tepper, J.M., Koos, T., Wilson, C.J., GABAergic microcircuits in the neostriatum. Trends Neurosci 27 (2004), 662–669.
24. 24 Kawaguchi, Y., Local Circuit Neurons in the Frontal Cortico-Striatal System. 2003, Springer, Boston.
25. 25 Haber, S.N., McFarland, N.R., The concept of the ventral striatum in nonhuman primates. Ann N Y Acad Sci 877 (1999), 33–48.
26. 26 Voorn, P., Vanderschuren, L.J., Groenewegen, H.J., Robbins, T.W., Pennartz, C.M., Putting a spin on the dorsal-ventral divide of the striatum. Trends Neurosci 27 (2004), 468–474.
27. 27 Joel, D., Weiner, I., The connections of the dopaminergic system with the striatum in rats and primates: An analysis with respect to the functional and compartmental organization of the striatum. Neuroscience 96 (2000), 451–474.
28. 28 Parent, A., Hazrati, L.N., Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop. Brain Res Rev 20 (1995), 91–127.
29. 29 Smith, Y., Raju, D.V., Pare, J.F., Sidibe, M., The thalamostriatal system: A highly specific network of the basal ganglia circuitry. Trends Neurosci 27 (2004), 520–527.
30. 30 Berendse, H.W., Galis-de Graaf, Y., Groenewegen, H.J., Topographical organization and relationship with ventral striatal compartments of prefrontal corticostriatal projections in the rat. J Comp Neurol 316 (1992), 314–347.
31. 31 Groenewegen, H.J., Berendse, H.W., Wolters, J.G., Lohman, A.H., The anatomical relationship of the prefrontal cortex with the striatopallidal system, the thalamus and the amygdala: Evidence for a parallel organization. Prog Brain Res 85 (1990), 95–116.
32. 32 Parent, A., Extrinsic connections of the basal ganglia. Trends Neurosci 13 (1990), 254–258.
33. 33 Ikemoto, S., Dopamine reward circuitry: Two projection systems from the ventral midbrain to the nucleus accumbens-olfactory tubercle complex. Brain Res Rev 56 (2007), 27–78.
34. 34 Zahm, D.S., Functional-anatomical implications of the nucleus accumbens core and shell subterritories. Ann N Y Acad Sci 877 (1999), 113–128.
35. 35 Floresco, S.B., The nucleus accumbens: An interface between cognition, emotion, and action. Annu Rev Psychol 66 (2015), 25–52.
36. 36 Baliki, M.N., Mansour, A., Baria, A.T., Huang, L., Berger, S.E., Fields, H.L., et al. Parceling human accumbens into putative core and shell dissociates encoding of values for reward and pain. J Neurosci 33 (2013), 16383–16393.
37. 37 Haber, S.N., Fudge, J.L., McFarland, N.R., Striatonigrostriatal pathways in primates form an ascending spiral from the shell to the dorsolateral striatum. J Neurosci 20 (2000), 2369–2382.
38. 38 Swanson, L.W., The projections of the ventral tegmental area and adjacent regions: A combined fluorescent retrograde tracer and immunofluorescence study in the rat. Brain Res Bull 9 (1982), 321–353.
39. 39 Yetnikoff, L., Lavezzi, H.N., Reichard, R.A., Zahm, D.S., An update on the connections of the ventral mesencephalic dopaminergic complex. Neuroscience 282 (2014), 23–48.
40. 40 Matsuda, W., Furuta, T., Nakamura, K.C., Hioki, H., Fujiyama, F., Arai, R., et al. Single nigrostriatal dopaminergic neurons form widely spread and highly dense axonal arborizations in the neostriatum. J Neurosci 29 (2009), 444–453.
41. 41 Doucet, G., Descarries, L., Garcia, S., Quantification of the dopamine innervation in adult rat neostriatum. Neuroscience 19 (1986), 427–445.
42. 42 Xia, Y., Driscoll, J.R., Wilbrecht, L., Margolis, E.B., Fields, H.L., Hjelmstad, G.O., Nucleus accumbens medium spiny neurons target non-dopaminergic neurons in the ventral tegmental area. J Neurosci 31 (2011), 7811–7816.
43. 43 Watabe-Uchida, M., Zhu, L., Ogawa, S.K., Vamanrao, A., Uchida, N., Whole-brain mapping of direct inputs to midbrain dopamine neurons. Neuron 74 (2012), 858–873.
44. 44 Lerner, T.N., Shilyansky, C., Davidson, T.J., Evans, K.E., Beier, K.T., Zalocusky, K.A., et al. Intact-brain analyses reveal distinct information carried by SNc dopamine subcircuits. Cell 162 (2015), 635–647.
45. 45 Menegas, W., Bergan, J.F., Ogawa, S.K., Isogai, Y., Umadevi Venkataraju, K., Osten, P., et al. Dopamine neurons projecting to the posterior striatum form an anatomically distinct subclass. Elife, 4, 2015, e10032.
46. 46 Tritsch, N.X., Sabatini, B.L., Dopaminergic modulation of synaptic transmission in cortex and striatum. Neuron 76 (2012), 33–50.
47. 47 Sulzer, D., Cragg, S.J., Rice, M.E., Striatal dopamine neurotransmission: Regulation of release and uptake. Basal ganglia 6 (2016), 123–148.
48. 48 Bamford, N.S., Zhang, H., Schmitz, Y., Wu, N.P., Cepeda, C., Levine, M.S., et al. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals. Neuron 42 (2004), 653–663.
49. 49 Kreitzer, A.C., Physiology and pharmacology of striatal neurons. Annu Rev Neurosci 32 (2009), 127–147.
50. 50 Gerfen, C.R., Surmeier, D.J., Modulation of striatal projection systems by dopamine. Annu Rev Neurosci 34 (2011), 441–466.
51. 51 Schultz, W., Updating dopamine reward signals. Curr Opin Neurobiol 23 (2013), 229–238.
52. 52 Salamone, J.D., Correa, M., The mysterious motivational functions of mesolimbic dopamine. Neuron 76 (2012), 470–485.
53. 53 Gunaydin, L.A., Grosenick, L., Finkelstein, J.C., Kauvar, I.V., Fenno, L.E., Adhikari, A., et al. Natural neural projection dynamics underlying social behavior. Cell 157 (2014), 1535–1551.
54. 54 Panigrahi, B., Martin, K.A., Li, Y., Graves, A.R., Vollmer, A., Olson, L., et al. Dopamine is required for the neural representation and control of movement vigor. Cell 162 (2015), 1418–1430.
55. 55 Beckstead, M.J., Grandy, D.K., Wickman, K., Williams, J.T., Vesicular dopamine release elicits an inhibitory postsynaptic current in midbrain dopamine neurons. Neuron 42 (2004), 939–946.
56. 56 Chuhma, N., Mingote, S., Moore, H., Rayport, S., Dopamine neurons control striatal cholinergic neurons via regionally heterogeneous dopamine and glutamate signaling. Neuron 81 (2014), 901–912.
57. 57 Straub, C., Tritsch, N.X., Hagan, N.A., Gu, C., Sabatini, B.L., Multiphasic modulation of cholinergic interneurons by nigrostriatal afferents. J Neurosci 34 (2014), 8557–8569.
58. 58 Tecuapetla, F., Patel, J.C., Xenias, H., English, D., Tadros, I., Shah, F., et al. Glutamatergic signaling by mesolimbic dopamine neurons in the nucleus accumbens. J Neurosci 30 (2010), 7105–7110.
59. 59 Marcott, P.F., Mamaligas, A.A., Ford, C.P., Phasic dopamine release drives rapid activation of striatal D2-receptors. Neuron 84 (2014), 164–176.
60. 60 Kitai, S.T., Sugimori, M., Kocsis, J.D., Excitatory nature of dopamine in the nigro-caudate pathway. Exp Brain Res 24 (1976), 351–363.
61. 61 Kaneko, T., Akiyama, H., Nagatsu, I., Mizuno, N., Immunohistochemical demonstration of glutaminase in catecholaminergic and serotoninergic neurons of rat brain. Brain Res 507 (1990), 151–154.
62. 62 Sulzer, D., Joyce, M.P., Lin, L., Geldwert, D., Haber, S.N., Hattori, T., et al. Dopamine neurons make glutamatergic synapses in vitro. J Neurosci 18 (1998), 4588–4602.
63. 63 Chuhma, N., Zhang, H., Masson, J., Zhuang, X., Sulzer, D., Hen, R., et al. Dopamine neurons mediate a fast excitatory signal via their glutamatergic synapses. J Neurosci 24 (2004), 972–981.
64. 64 Hnasko, T.S., Chuhma, N., Zhang, H., Goh, G.A., Sulzer, D., Palmiter, R.D., et al. Vesicular glutamate transport promotes dopamine storage and glutamate corelease in vivo. Neuron 65 (2010), 643–656.
65. 65 Stuber, G.D., Hnasko, T.S., Britt, J.P., Edwards, R.H., Bonci, A., Dopaminergic terminals in the nucleus accumbens but not the dorsal striatum corelease glutamate. J Neurosci 30 (2010), 8229–8233.
66. 66 Wieland, S., Du, D., Oswald, M.J., Parlato, R., Kohr, G., Kelsch, W., Phasic dopaminergic activity exerts fast control of cholinergic interneuron firing via sequential NMDA, D2, and D1 receptor activation. J Neurosci 34 (2014), 11549–11559.
67. 67 Mingote, S., Chuhma, N., Kusnoor, S.V., Field, B., Deutch, A.Y., Rayport, S., Functional connectome analysis of dopamine neuron glutamatergic connections in forebrain regions. J Neurosci 35 (2015), 16259–16271.
68. 68 Tritsch, N.X., Ding, J.B., Sabatini, B.L., Dopaminergic neurons inhibit striatal output through non-canonical release of GABA. Nature 490 (2012), 262–266.
69. 69 Tritsch, N.X., Oh, W.J., Gu, C., Sabatini, B.L., Midbrain dopamine neurons sustain inhibitory transmission using plasma membrane uptake of GABA, not synthesis. eLife, 3, 2014, e01936.
70. 70 Kim, J.I., Ganesan, S., Luo, S.X., Wu, Y.W., Park, E., Huang, E.J., et al. Aldehyde dehydrogenase 1a1 mediates a GABA synthesis pathway in midbrain dopaminergic neurons. Science 350 (2015), 102–106.
71. 71 Brown, M.T.C., Tan, K.R., O'Connor, E.C., Nikonenko, I., Muller, D., Lüscher, C., Ventral tegmental area GABA projections pause accumbal cholinergic interneurons to enhance associative learning. Nature 492 (2012), 452–456.
72. 72 Taylor, S.R., Badurek, S., Dileone, R.J., Nashmi, R., Minichiello, L., Picciotto, M.R., GABAergic and glutamatergic efferents of the mouse ventral tegmental area. J Comp Neurol 522 (2014), 3308–3334.
73. 73 Morales, M., Root, D.H., Glutamate neurons within the midbrain dopamine regions. Neuroscience 282C (2014), 60–68.
74. 74 Pennartz, C.M., Berke, J.D., Graybiel, A.M., Ito, R., Lansink, C.S., van der Meer, M., et al. Corticostriatal interactions during learning, memory processing, and decision making. J Neurosci 29 (2009), 12831–12838.
75. 75 Maurin, Y., Banrezes, B., Menetrey, A., Mailly, P., Deniau, J.M., Three-dimensional distribution of nigrostriatal neurons in the rat: relation to the topography of striatonigral projections. Neuroscience 91 (1999), 891–909.
76. 76 Lyon, G.J., Abi-Dargham, A., Moore, H., Lieberman, J.A., Javitch, J.A., Sulzer, D., Presynaptic regulation of dopamine transmission in schizophrenia. Schizophr Bull 37 (2011), 108–117.
77. 77 Rice, M.E., Patel, J.C., Cragg, S.J., Dopamine release in the basal ganglia. Neuroscience 198 (2011), 112–137.
78. 78 Brimblecombe, K.R., Cragg, S.J., Substance P weights striatal dopamine transmission differently within the striosome-matrix axis. J Neurosci 35 (2015), 9017–9023.
79. 79 Cachope, R., Cheer, J.F., Local control of striatal dopamine release. Front Behav Neurosci, 8, 2014, 188.
80. 80 Marenco, S., Carson, R.E., Berman, K.F., Herscovitch, P., Weinberger, D.R., Nicotine-induced dopamine release in primates measured with [11C]raclopride PET. Neuropsychopharmacology 29 (2004), 259–268.
81. 81 Olincy, A., Freedman, R., Nicotinic mechanisms in the treatment of psychotic disorders: a focus on the α7 nicotinic receptor. Handb Exp Pharmacol 213 (2012), 211–232.
82. 82 Leonard, S., Mexal, S., Freedman, R., Smoking, genetics and schizophrenia: Evidence for self medication. J Dual Diagn 3 (2007), 43–59.
83. 83 Freedman, R., alpha7-nicotinic acetylcholine receptor agonists for cognitive enhancement in schizophrenia. Annu Rev Med 65 (2014), 245–261.
84. 84 Ross, R.G., Hunter, S.K., McCarthy, L., Beuler, J., Hutchison, A.K., Wagner, B.D., et al. Perinatal choline effects on neonatal pathophysiology related to later schizophrenia risk. Am J Psychiatry 170 (2013), 290–298.
85. 85 Holt, D.J., Bachus, S.E., Hyde, T.M., Wittie, M., Herman, M.M., Vangel, M., et al. Reduced density of cholinergic interneurons in the ventral striatum in schizophrenia: An in situ hybridization study. Biol Psychiatry 58 (2005), 408–416.
86. 86 Scarr, E., Gibbons, A.S., Neo, J., Udawela, M., Dean, B., Cholinergic connectivity: Its implications for psychiatric disorders. Front Cell Neurosci, 7, 2013, 55.
87. 87 Zhang, H., Sulzer, D., Frequency-dependent modulation of dopamine release by nicotine. Nat Neurosci 7 (2004), 581–582.
88. 88 Kapur, S., Mizrahi, R., Li, M., From dopamine to salience to psychosis–linking biology, pharmacology and phenomenology of psychosis. Schizophr Res 79 (2005), 59–68.
89. 89 Cachope, R., Mateo, Y., Mathur, B.N., Irving, J., Wang, H.L., Morales, M., et al. Selective activation of cholinergic interneurons enhances accumbal phasic dopamine release: Setting the tone for reward processing. Cell Rep 2 (2012), 33–41.
90. 90 Threlfell, S., Lalic, T., Platt, N.J., Jennings, K.A., Deisseroth, K., Cragg, S.J., Striatal dopamine release is triggered by synchronized activity in cholinergic interneurons. Neuron 75 (2012), 58–64.
91. 91 Wang, L., Zhang, X., Xu, H., Zhou, L., Jiao, R., Liu, W., et al. Temporal components of cholinergic terminal to dopaminergic terminal transmission in dorsal striatum slices of mice. J Physiol 592 (2014), 3559–3576.
92. 92 Threlfell, S., Cragg, S.J., Dopamine signaling in dorsal versus ventral striatum: The dynamic role of cholinergic interneurons. Front Syst Neurosci, 5, 2011, 11.
93. 93 Patel, J.C., Rice, M.E., Monitoring axonal and somatodendritic dopamine release using fast-scan cyclic voltammetry in brain slices. Methods Mol Biol 964 (2013), 243–273.
94. 94 Exley, R., Clements, M.A., Hartung, H., McIntosh, J.M., Cragg, S.J., Alpha6-containing nicotinic acetylcholine receptors dominate the nicotine control of dopamine neurotransmission in nucleus accumbens. Neuropsychopharmacology 33 (2008), 2158–2166.
95. 95 Threlfell, S., Clements, M.A., Khodai, T., Pienaar, I.S., Exley, R., Wess, J., et al. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum. J Neurosci 30 (2010), 3398–3408.
96. 96 Patel, J.C., Rossignol, E., Rice, M.E., Machold, R.P., Opposing regulation of dopaminergic activity and exploratory motor behavior by forebrain and brainstem cholinergic circuits. Nature Commun, 3, 2012, 1172.
97. 97 Rice, M.E., Cragg, S.J., Nicotine amplifies reward-related dopamine signals in striatum. Nat Neurosci 7 (2004), 583–584.
98. 98 El Mestikawy, S., Wallen-Mackenzie, A., Fortin, G.M., Descarries, L., Trudeau, L.E., From glutamate co-release to vesicular synergy: Vesicular glutamate transporters. Nat Rev Neurosci 12 (2011), 204–216.
99. 99 Hnasko, T.S., Edwards, R.H., Neurotransmitter corelease: Mechanism and physiological role. Annu Rev Physiol 74 (2012), 225–243.
100. 100 Zhang, S., Qi, J., Li, X., Wang, H.-L., Britt, J.P., Hoffman, A.F., et al. Dopaminergic and glutamatergic microdomains in a subset of rodent mesoaccumbens axons. Nat Neurosci 18 (2015), 386–392.
101. 101 Brimblecombe, K.R., Gracie, C.J., Platt, N.J., Cragg, S.J., Gating of dopamine transmission by calcium and axonal N-, Q-, T- and L-type voltage-gated calcium channels differs between striatal domains. J Physiol 593 (2015), 929–946.
102. 102 Cragg, S.J., Variable dopamine release probability and short-term plasticity between functional domains of the primate striatum. J Neurosci 23 (2003), 4378–4385.
103. 103 Blanchard, V., Raisman-Vozari, R., Vyas, S., Michel, P.P., Javoy-Agid, F., Uhl, G., et al. Differential expression of tyrosine hydroxylase and membrane dopamine transporter genes in subpopulations of dopaminergic neurons of the rat mesencephalon. Brain Res Mol Brain Res 22 (1994), 29–38.
104. 104 Hurd, Y.L., Pristupa, Z.B., Herman, M.M., Niznik, H.B., Kleinman, J.E., The dopamine transporter and dopamine D2 receptor messenger RNAs are differentially expressed in limbic- and motor-related subpopulations of human mesencephalic neurons. Neuroscience 63 (1994), 357–362.
105. 105 Lammel, S., Hetzel, A., Häckel, O., Jones, I., Liss, B., Roeper, J., Unique properties of mesoprefrontal neurons within a dual mesocorticolimbic dopamine system. Neuron 57 (2008), 760–773.
106. 106 Cragg, S.J., Hille, C.J., Greenfield, S.A., Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine. J Neurosci 22 (2002), 5705–5712.
107. 107 Paladini, C.A., Roeper, J., Generating bursts (and pauses) in the dopamine midbrain neurons. Neuroscience 282C (2014), 109–121.
108. 108 Morikawa, H., Paladini, C.A., Dynamic regulation of midbrain dopamine neuron activity: Intrinsic, synaptic, and plasticity mechanisms. Neuroscience 198 (2011), 95–111.
109. 109 Wolfart, J., Neuhoff, H., Franz, O., Roeper, J., Differential expression of the small-conductance, calcium-activated potassium channel SK3 is critical for pacemaker control in dopaminergic midbrain neurons. J Neurosci 21 (2001), 3443–3456.
110. 110 Mercuri, N.B., Bonci, A., Calabresi, P., Stratta, F., Stefani, A., Bernardi, G., Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. Br J Pharmacol 113 (1994), 831–838.
111. 111 Khaliq, Z.M., Bean, B.P., Pacemaking in dopaminergic ventral tegmental area neurons: Depolarizing drive from background and voltage-dependent sodium conductances. J Neurosci 30 (2010), 7401–7413.
112. 112 Schiemann, J., Schlaudraff, F., Klose, V., Bingmer, M., Seino, S., Magill, P.J., et al. K-ATP channels in dopamine substantia nigra neurons control bursting and novelty-induced exploration. Nat Neurosci 15 (2012), 1272–1280.
113. 113 Zweifel, L.S., Parker, J.G., Lobb, C.J., Rainwater, A., Wall, V.Z., Fadok, J.P., et al. Disruption of NMDAR-dependent burst firing by dopamine neurons provides selective assessment of phasic dopamine-dependent behavior. Proc Natl Acad Sci U S A 106 (2009), 7281–7288.
114. 114 Krabbe, S., Duda, J., Schiemann, J., Poetschke, C., Schneider, G., Kandel, E.R., et al. Increased dopamine D2 receptor activity in the striatum alters the firing pattern of dopamine neurons in the ventral tegmental area. Proc Natl Acad Sci U S A 112 (2015), E1498–1506.
115. 115 Soden, M.E., Jones, G.L., Sanford, C.A., Chung, A.S., Guler, A.D., Chavkin, C., et al. Disruption of dopamine neuron activity pattern regulation through selective expression of a human KCNN3 mutation. Neuron 80 (2013), 997–1009.
116. 116 Sarpal, D., Koenig, J., Adelman, J.P., Brady, D., Prendeville, L., Shepard, P., Regional distribution of SK3 mRNA-containing neurons in the adult and adolescent rat ventral midbrain and their relationship to dopamine-containing cells. Synapse 53 (2004), 104–113.
117. 117 Laruelle, M., Imaging neurotransmission with in vivo binding competition techniques: A critical review. J Cereb Blood Flow Metab 20 (2000), 423–451.
118. 118 Floresco, S.B., West, A.R., Ash, B., Moore, H., Grace, A.A., Afferent modulation of dopamine neuron firing differentially regulates tonic and phasic dopamine transmission. Nat Neurosci 6 (2003), 968–973.
119. 119 Owesson-White, C.A., Roitman, M.F., Sombers, L.A., Belle, A.M., Keithley, R.B., Peele, J.L., et al. Sources contributing to the average extracellular concentration of dopamine in the nucleus accumbens. J Neurochem 121 (2012), 252–262.
120. 120 Sombers, L.A., Beyene, M., Carelli, R.M., Wightman, R.M., Synaptic overflow of dopamine in the nucleus accumbens arises from neuronal activity in the ventral tegmental area. J Neurosci 29 (2009), 1735–1742.
121. 121 Martinez, D., Slifstein, M., Broft, A., Mawlawi, O., Hwang, D.R., Huang, Y., et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: Amphetamine-induced dopamine release in the functional subdivisions of the striatum. J Cereb Blood Flow Metab 23 (2003), 285–300.
122. 122 Riccardi, P., Li, R., Ansari, M.S., Zald, D., Park, S., Dawant, B., et al. Amphetamine-induced displacement of [18F] fallypride in striatum and extrastriatal regions in humans. Neuropsychopharmacology 31 (2006), 1016–1026.
123. 123 Yates, J.W., Meij, J.T.A., Sullivan, J.R., Richtand, N.M., Yu, L., Bimodal effect of amphetamine on motor behaviors in C57BL/6 mice. Neurosci Lett 427 (2007), 66–70.
124. 124 Kelly, P.H., Seviour, P.W., Iversen, S.D., Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Res 94 (1975), 507–522.
125. 125 Michel, A., Tirelli, E., Conditioned hyperkinesia induced by cocaine in mice is dose-dependent but not correlated with the unconditioned response or the contextually-sensitized response. Behav Pharmacol 13 (2002), 59–71.
126. 126 Birgner, C., Nordenankar, K., Lundblad, M., Mendez, J.A., Smith, C., le Greves, M., et al. VGLUT2 in dopamine neurons is required for psychostimulant-induced behavioral activation. Proc Natl Acad Sci U S A 107 (2010), 389–394.
127. 127 Fortin, G.M., Bourque, M.J., Mendez, J.A., Leo, D., Nordenankar, K., Birgner, C., et al. Glutamate corelease promotes growth and survival of midbrain dopamine neurons. J Neurosci 32 (2012), 17477–17491.
128. 128 Sakae, D.Y., Marti, F., Lecca, S., Vorspan, F., Martin-Garcia, E., Morel, L.J., et al. The absence of VGLUT3 predisposes to cocaine abuse by increasing dopamine and glutamate signaling in the nucleus accumbens. Mol Psychiatry 20 (2015), 1448–1459.
129. 129 De Duve, C., De Barsy, T., Poole, B., Troulet, A., Tulkens, P., Van Hoof, F., Lysosomotrophic agents. Biochem Pharmacol 23 (1974), 2495–2531.
130. 130 Rayport, S., Sulzer, D., Visualization of antipsychotic binding to living mesolimbic neurons reveals D2 receptor mediated, acidotropic and lipophilic components. J Neurochem 65 (1995), 691–703.
131. 131 Tucker, K.R., Block, E.R., Levitan, E.S., Action potentials and amphetamine release antipsychotic drug from dopamine neuron synaptic VMAT vesicles. Proc Natl Acad Sci U S A 112 (2015), E4485–4494.
132. 132 Schmalzing, G., The role of a transmembrane pH gradient in uptake and release of imipramine and haloperidol in synaptosomes. Mol Pharmacol 34 (1988), 888–895.
133. 133 Tischbirek, C.H., Wenzel, E.M., Zheng, F., Huth, T., Amato, D., Trapp, S., et al. Use-dependent inhibition of synaptic transmission by the secretion of intravesicularly accumulated antipsychotic drugs. Neuron 74 (2012), 830–844.
134. 134 Kornhuber, J., Schultz, A., Wiltfang, J., Meineke, I., Gleiter, C.H., Zochling, R., et al. Persistence of haloperidol in human brain tissue. Am J Psychiatry 156 (1999), 885–890.
135. 135 Gemperle, A.Y., Enz, A., Pozza, M.F., Luthi, A., Olpe, H.R., Effects of clozapine, haloperidol and iloperidone on neurotransmission and synaptic plasticity in prefrontal cortex and their accumulation in brain tissue: an in vitro study. Neuroscience 117 (2003), 681–695.
136. 136 Mai, J.K., Assheuer, J., Paxinos, G., Atlas of the Human Brain. 2nd ed., 2004, Elsevier Academic Press, Amsterdam.
137. 137 Paxinos, G., Franklin, K.B.J., Paxinos and Franklinʼs the Mouse Brain in Stereotaxic Coordinates. 4th ed., 2013, Academic Press, Amsterdam.
138. 138 Haber, S.N., Behrens, T.E.J., The neural network underlying incentive-based learning: Implications for interpreting circuit disruptions in psychiatric disorders. Neuron 83 (2014), 1019–1039.